EP2147122
Ensím meðferð gegn krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.4.2008EP published:
16.7.2014EP application number:
08754910.1
EP translation filed:
23.9.2014Grant published:
15.10.2014EPO information:
European Patent Register
Max expiry date:
17.4.2028Expiry date:
17.4.2026Next due date:
30.4.2026
Title:
ENZYMATIC ANTICANCER THERAPY
Timeline
Owner
Name:
UNIKERIS LIMITEDAddress:
333 Styal Road, M22 5LG, Manchester, GB
Inventor
Name:
FILPULA, David R.Address:
Piscataway, NJ, US
Name:
SAPRA, PujaAddress:
Edison, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
913039 PDate:
20.4.2007Country:
US
Classification
Categories:
C12Q 1/68, A61K 38/50, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 31.3.2015
Expires: 17.4.2016
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 20.4.2016
Expires: 17.4.2017
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 21.3.2017
Expires: 17.4.2018
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 21.3.2018
Expires: 17.4.2019
Payer: G. H. Sigurgeirsson
Number: 12
Paid: 10.4.2019
Expires: 17.4.2020
Payer: G. H. Sigurgeirsson
Number: 13
Paid: 19.3.2020
Expires: 17.4.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 14
Paid: 12.4.2021
Expires: 17.4.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 15
Paid: 31.3.2022
Expires: 17.4.2023
Payer: Patice ehf.
Number: 16
Paid: 31.3.2023
Expires: 17.4.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 2.4.2024
Expires: 17.4.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 14.4.2025
Expires: 17.4.2026
Payer: Árnason Faktor ehf.